Ophthalmic Imaging in HCHWA-D

• Conditions: Hereditary Cerebral Hemorrhage With Amyloidosis-Dutchtype; amyloid angiopathy; Katwijkse ziekte; 10047060; 10007963

• Registration Number: NL-OMON40430
• Lead Sponsor: Oogheelkunde

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

DNA-proven patients with HCHWA-D or patients with a strong clinical suspicion for HCHWA-D in combination with MRI-scan abnormalities highly suggesting HCHWA-D. Patients must be willing to be informed about their test results and (clinical) diagnosis.

Exclusion Criteria

Direct family members of the patients whom genetic testing is not performed and/or are nog willing to be informed about their test results and (clinical) diagnosis;
Age-related Macular Dystrophy (AMD);
Diabetic Mellitus;
Macular dystrophies;
Eye traumas;
Glaucoma

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Differences between the opthalmic findings in HCHWA-D patients and controls.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>